169 related articles for article (PubMed ID: 21927961)
1. Preparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cells.
Gu X; Zhang W; Liu J; Shaw JP; Shen Y; Xu Y; Lu H; Wu Z
AAPS PharmSciTech; 2011 Dec; 12(4):1200-8. PubMed ID: 21927961
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
3. Influence of Fatty Acid Modification on Uptake of Lovastatin-Loaded Reconstituted High Density Lipoprotein by Foam Cells.
Yang Y; Wang J; He H; Zhang W; Zhang Y; Liu J
Pharm Res; 2018 May; 35(7):134. PubMed ID: 29736804
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.
He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J
Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440
[TBL] [Abstract][Full Text] [Related]
5. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.
Zhou J; Zhou D
Drug Des Devel Ther; 2015; 9():5269-75. PubMed ID: 26425076
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
7. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
[TBL] [Abstract][Full Text] [Related]
9. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
10. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
[TBL] [Abstract][Full Text] [Related]
12. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
13. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
[TBL] [Abstract][Full Text] [Related]
14. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].
Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK
Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576
[TBL] [Abstract][Full Text] [Related]
15. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
[TBL] [Abstract][Full Text] [Related]
16. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
[TBL] [Abstract][Full Text] [Related]
17. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.
Ruktanonchai U; Bejrapha P; Sakulkhu U; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
AAPS PharmSciTech; 2009; 10(1):227-34. PubMed ID: 19280350
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
20. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]